ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 50 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,751,000 | +16.1% | 65,683 | +5.6% | 0.79% | +7.9% |
| Q4 2017 | $4,093,000 | -12.1% | 62,172 | -33.1% | 0.73% | +18.4% |
| Q3 2017 | $4,656,000 | +0.4% | 92,899 | -7.3% | 0.62% | -19.2% |
| Q2 2017 | $4,636,000 | +2.3% | 100,170 | -21.9% | 0.77% | +7.3% |
| Q1 2017 | $4,530,000 | -45.2% | 128,300 | +43.6% | 0.71% | -25.2% |
| Q1 2015 | $8,272,000 | +11.2% | 89,335 | -51.5% | 0.96% | -8.0% |
| Q4 2014 | $7,442,000 | +341.4% | 184,020 | +167.0% | 1.04% | +202.6% |
| Q3 2014 | $1,686,000 | – | 68,921 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |